Free Trial
OTCMKTS:OSIR

Osiris Therapeutics (OSIR) Stock Price, News & Analysis

Osiris Therapeutics logo
$18.99
0.00 (0.00%)
(As of 04/17/2019)

About Osiris Therapeutics Stock (OTCMKTS:OSIR)

Key Stats

Today's Range
$18.99
$18.99
50-Day Range
$18.99
$18.99
52-Week Range
$7.01
$19.30
Volume
N/A
Average Volume
205,753 shs
Market Capitalization
$655.69 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Osiris Therapeutics, Inc. researches, develops, manufactures, markets, and distributes regenerative medicine products in the United States. Its products include Grafix and Stravix for treating chronic wounds of diabetic foot ulcers, venous leg ulcers, pressure ulcers, arterial ulcers, and severe burns, as well as surgical and trauma wounds; BIO4 for bone repair and regeneration in spine, trauma, extremity, cranial, and foot and ankle surgeries; and Cartiform for treating articular cartilage lesions in the knee and other joints. The company also develops and markets Menvivo for the repair of meniscus; and TruSkin for treating chronic wounds. It markets and distributes its products directly to physicians, hospitals, and other healthcare providers, as well as through agents and distributors. Osiris Therapeutics, Inc. was founded in 1992 and is headquartered in Columbia, Maryland.

Receive OSIR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Osiris Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

OSIR Stock News Headlines

Kanak Kanti
True paradigm shift
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
See More Headlines

OSIR Stock Analysis - Frequently Asked Questions

Osiris Therapeutics' stock was trading at $18.99 at the beginning of 2024. Since then, OSIR shares have increased by 0.0% and is now trading at $18.99.
View the best growth stocks for 2024 here
.

Shares of OSIR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Osiris Therapeutics investors own include Sierra Wireless (SWIR), MiMedx Group (MDXG), Achillion Pharmaceuticals (ACHN), Mallinckrodt (MNK), Bristol-Myers Squibb (BMY), Ionis Pharmaceuticals (IONS) and Mesoblast (MESO).

Industry, Sector and Symbol

Sector
Medical
Industry
Biological Products, Except Diagnostic
Sub-Industry
Biotechnology
Current Symbol
OTCMKTS:OSIR
Previous Symbol
NASDAQ:OSIR
CUSIP
68827R10
Fax
N/A
Employees
342
Year Founded
1992

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Market Cap
$655.69 million
Optionable
Not Optionable
Beta
N/A

Social Links

The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

This page (OTCMKTS:OSIR) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners